You et al. (2022) pioneered the study on immune subtype of mRNA vaccination for STAD and identified ADAMTS18, COL10A1, PPEF1, and STRA6 as potential mRNA vaccine candidates. Here, PPEF1 is linked to gastric adenocarcinoma.